Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Medingo Medical Solutions

Request full access

Medingo develops and manufactures miniature medical devices to treat people with diabetes

IsraelFounded 2005Biotech & Life Sciences

About Medingo Medical Solutions

Medingo Medical Solutions was an Israeli company focused on the development of miniature medical devices for people with diabetes. Founded in 2005 by Dr. Ofer Yodfat, the company operated from Yokneam Illit, Israel. Prior to its acquisition, Medingo secured $27 million in a Series A funding round on November 20, 2007, with investors including Elron Ventures and Radius Ventures.

The company's core product was the Solo MicroPump Insulin Delivery System. This device was designed as a small, tube-free insulin patch pump, aiming to offer users a more discreet and flexible method for insulin management. The system consisted of two main components: a semi-disposable insulin-dispensing patch and a wireless remote control for personalized programming and data management. A key feature was the ability to detach the pump from the adhesive cradle on the skin, as well as the option to administer a bolus directly from the pump without the remote. The Solo MicroPump was composed of a reusable pump base, a disposable 200-unit insulin reservoir, and a disposable cradle that was replaced every three days. This modular design was also presented as a more environmentally friendly and economical alternative to fully disposable systems.

Medingo received FDA clearance to market the Solo MicroPump in the United States in July 2009. In April 2010, the Swiss healthcare company Roche announced its acquisition of Medingo for an upfront payment of $160 million, with potential for up to an additional $40 million in performance-based milestones. The acquisition made Medingo a wholly-owned subsidiary of Roche, with the goal of integrating the Solo pump into Roche's Diabetes Care portfolio. At the time of the acquisition, the Solo pump was not yet commercially marketed, and Roche planned for a global launch by 2012 after scaling up production capabilities.

Source: Dealroom company data

Medingo Medical Solutions in its local ecosystem

Live from Dealroom

The Medingo Medical Solutions office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Elron
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇱 Israel62.5%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Medingo Medical Solutions on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medingo Medical Solutions on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.